Friday broker round-up
4th May 2012 09:21
AstraZeneca: UBS raises target from 3,400p to 3,500p, buy rating unchanged. BG Group: Nomura cuts target from 1,950p to 1,850p, buy rating kept. British Land: Jefferies upgrades British Land from hold to buy, targetupped from 517p to 543p. Dairy Crest: Jefferies initiates coverage with a buy reco
Read moreLondon midday: Footsie down as Man Group provides a drag
30th Apr 2012 11:48
- Spain joins the UK in recession - Man Group volatile ahead of Q1 IMS - Aberdeen up after solid first half London's blue chip index was trading near its lowest levels of the day by Monday lunchtime, snapping a four-day winning streak as Eurozone concerns were once again brought into the spotlight.
Read moreLondon open: Markets cautious early on, Spain in focus
30th Apr 2012 08:32
- Aberdeen leads risers after solid first half - Randgold falls after broker downgrade - Spain focus ahead of Thursday's bond auction Following a four-day winning streak, the FTSE 100 opened broadly flat on Monday morning with the Eurozone again in focus as Spanish debt concerns continue to weigh
Read moreMonday broker round-up
30th Apr 2012 08:29
Anglo American: AlphaValue downgrades from neutral to reduce, target cut from 7,115p to 6,970p. AstraZeneca: Jefferies upgrades from hold to buy, target cut from 3,050p to 2,975p; JP Morgan Cazenove upgrades from underweight to neutral, target hiked from 2,800p to 3,050p. British Sky Broadcasting:
Read moreLondon midday: Stocks rise as markets await US GDP data
27th Apr 2012 11:56
- US futures flat ahead of GDP data - UK investors shrug off Spanish downgrade - Man, CRH, British Land rise after upgrades The Footsie was trading firmly higher on Friday morning as investors shrugged off a downgrade for Spain and some disappointing UK economic data. US stock futures were pointi
Read moreFriday broker round-up - UPDATE
27th Apr 2012 09:21
AstraZeneca: Credit Suisse maintains underperform rating and 2,600p target. ASOS: HSBC upgrades from neutral to overweight, target cut from 1,900p to 1,780p. Barclays: Nomura reiterates neutral recommendation and 268p target. British American Tobacco: Jefferies maintains buy recommendation and 3,
Read moreLondon close: Whitbread leads the Footsie higher
26th Apr 2012 16:41
- Whitbread up 6pc, Astra down 6pc - Economic data from UK and US comes in mixed - Fed sees growth picking up gradually The Footsie rallied in afternoon trade to finish close to its intraday highs reached in the morning session. Investors had to digest a barrage of company results and trading updat
Read moreSector movers: Unilever boosts food sector, Astra drags down pharmas
26th Apr 2012 15:45
The food producing and processing sector was the best performing sector on Thursday afternoon, with heavyweight constituent Unilever providing a lift following its first-quarter statement. The consumer goods giant, famous for food brands such as Flora, Ben & Jerry's, PG Tips and Pot Noodle (as well
Read moreBroker tips: Barclays, AstraZeneca, Whitbread
26th Apr 2012 12:49
Nomura has maintained its neutral rating and 268p target price for UK lender Barclays saying that while the first-quarter results were slightly better than expectations, the second-quarter outlook is 'deteriorating'. Barclays said that while the first-quarter performance was "encouraging", "the con
Read moreLondon midday: Footsie flat as AstraZeneca provides a drag
26th Apr 2012 11:51
- Footsie flat after strong start - AstraZeneca drops after disappointing first-quarter results - Domestic economic data comes in mixed After a strong rise early on, the FTSE 100 had erased gains to trade broadly flat by lunchtime after a mixed reception to a barrage of company results and trading
Read moreBroker snap: Astra's guidance cut comes as a surprise, says Jefferies
26th Apr 2012 11:11
Jefferies has maintained its cautious stance on pharmaceuticals giant AstraZeneca after the group missed consensus revenue estimates by eight per cent in the first quarter. Revenues came in well below market expectations, falling 11% to $7.349bn, compared with Jefferies forecasts of $7.58bn and con
Read moreThursday broker round-up - UPDATE
26th Apr 2012 08:36
Admiral: Oriel Securities retains sell rating and 740p target. AstraZeneca: Panmure Gordon maintains buy rating and 3,600p target. Barclays: Nomura reiterates neutral rating and 268p target; Exane BNP Paribas keeps outperform rating and 300p target; Oriel Securities keeps buy rating and 285p targe
Read moreLondon open: Footsie rises after barrage of results
26th Apr 2012 08:36
- Unilever, Shell, Whitbread, Barclays rise after results/updates - Astra, Croda, Admiral provide a drag - Fed expects growth to 'pick up gradually' The FTSE 100 was heading for its third consecutive rise on Thursday with some well-received results from Unilever, Royal Dutch Shell, Whitbread and Ba
Read moreLondon pre-open: Small rise expected in early trading
26th Apr 2012 07:39
City sources predict the FTSE 100 will open up 13 points from yesterday's close of 5,719, following comments from Federal Reserve Chairman Ben Bernanke on Wednesday that US monetary policy was 'more or less in the right place', indicating further quantitative easing in the near-term is unlikely.
Read moreProfits plunge and CEO to go at AstraZeneca
26th Apr 2012 07:07
Pharmaceuticals giant AstraZeneca said profits fell by more than a third in the first quarter after a number of patents ran out and it was hit by tough market conditions. This led it to downgrade its full year earnings prospects. The company also announced that Chief Executive David Brennan would
Read more